Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
for
Lymphocytic Leukemia, Chronic, SLL
Location: Boston MA, Durham NC
Sponsor: Catapult Therapeutics
Sex: All
Age: 18+
Code: NCT04704323
Phase1, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Boston MA, Providence RI, Springfield MA, Hartford CT,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
for
Lymphocytic Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03219450
Phase1, Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: Boston MA, New York NY, Fairfax VA, Columbus OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06561685
Phase1, Recruiting
Distal Radius Interventions for Fracture Treatment
for
Fracture Distal Radius
Location: Boston MA, The Bronx NY, New York NY, New Brunswick NJ,
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Sex: All
Age: 4 - 10
Code: NCT05131685
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
Resilience and Equity in Aging, Cancer, and Health (REACH)
Noise-Enhanced Sensory Function in Elders at Risk for Falls
for
Aging, Somatosensory Deficit
Location: Boston MA
Sponsor: National Institute on Aging (NIA)
Sex: All
Age: 70+
Code: NCT00421759
Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Boston MA, Springfield MA, New Haven CT, Portland ME,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Prism Adaptation Therapy (PAT) for Right Brain Stroke Rehabilitation
for
Spatial Neglect After Right Brain Stroke
Location: Leeds MA, West Haven CT, Cleveland OH, Decatur GA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05983185
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Farmington CT, Shirley NY, Lake Success NY,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase3, Recruiting
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
for
Delirium
Location: Boston MA, The Bronx NY, New York NY, Baltimore MD,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 60+
Code: NCT06192615
Phase3, Recruiting
Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA
for
OSA
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 21 - 70+
Code: NCT06091085
Phase1, Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Boston MA, Philadelphia PA, Fairfax VA, Cleveland OH,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase1, Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Venous Thrombectomy/Thrombolysis Outcome Registry
for
Deep Venous Thrombosis, Post Thrombotic Syndrome
Location: Beverly MA
Sponsor: Heart and Vascular Outcomes Research Institute
Sex: All
Age: 16 - 70+
Code: NCT02113475
Recruiting
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
for
Mutant IDH1 Inhibitor Olutasidenib
Location: Boston MA, Buffalo NY, Westwood KS, Miami FL,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06445959
Phase1, Phase2, Recruiting
Use of a Predictive Analytics Algorithm to Optimize Weaning of Inotropes Following Pediatric Cardiac Surgery
for
Congenital Heart Disease
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: All
Age: 0 - 1
Code: NCT04600700
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma